Concepedia

Leena Gandi

LG

2

Publications

28

Citations

2

H-Index

2013

Active since

Affiliations

Massachusetts General Hospital(Current)

Dana-Farber Cancer Institute

Leena Gandi is an author at Massachusetts General Hospital specializing in cancer cell biology, cancer therapeutics, and tumor biology.

Top concepts

MedicineOncologyPathologyPharmacologyTumor BiologyCancer TherapyCancer ResearchMolecular OncologyRadiation OncologyCancer Cell Biology

Publications per year

2013–2017

2

Publications

2

Abstract LB-147: Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial.

Jeffrey R. Infante, Leena Gandi, Geoffrey I. Shapiro et al. · Cancer Research · 2013 · 18 citations

Pathology, Pi3k/mtor Inhibitor, Mek Inhibitor +16

Abstract CT046: Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD-0325901 in patients with <i>RAS</i> mutant solid tumors

Geoffrey I. Shapiro, John Hilton, Leena Gandi et al. · Cancer Research · 2017 · 10 citations

Rows per page

1–2 of 2